Description
BSE revises price bands for 20 scrips including Aerpace Industries, Bandaram Pharma, HRS Aluglaze and others, effective from January 2, 2026.
Summary
BSE has revised the price bands for 20 equity scrips effective from January 2, 2026. The revised price bands range from 2% to 20%, applied to various companies across different sectors. Trading members are advised to note these changes for their trading operations.
Key Points
- 20 scrips affected by price band revisions
- Effective date: January 2, 2026
- Price bands revised to varying levels: 2%, 5%, 10%, and 20%
- Notice issued by BSE Surveillance department
- Scrips include companies from industries like aerospace, pharmaceuticals, footwear, metals, and others
Regulatory Changes
Price band adjustments for the following securities:
- 2% Band: Bandaram Pharma Packtech Ltd (524602), Organic Coatings Ltd (531157), Tejassvi Aaharam Ltd (531628)
- 5% Band: Integrated Industries Ltd (531889), Kiduja India Ltd (507946), LE Lavoir Ltd (539814), Nagpur Power & Industries Ltd (532362), Shiva Granito Export Ltd (540072), Shree Metalloys Ltd (531962), Trustedge Capital Ltd (532056), Western Overseas Study Abroad Ltd (544636)
- 10% Band: Aerpace Industries Ltd (534733), Jupiter Infomedia Ltd (534623), KSR Footwear Ltd (544615), Palco Metals Ltd (539121), TILAK VENTURES LIMITED (751068), Vision Cinemas Ltd (526441), Vivimed Labs Ltd (532660)
- 20% Band: HRS Aluglaze Ltd (544656), Pajson Agro India Ltd (544657)
Compliance Requirements
- Trading members must adjust their trading systems to reflect the new price bands
- Members should ensure compliance with revised price band limits for all affected scrips
- For clarifications, members may contact BSE at bse.surv@bseindia.com
Important Dates
- Notice Date: January 1, 2026
- Effective Date: January 2, 2026
Impact Assessment
The price band revisions affect trading volatility limits for 20 securities. Tighter bands (2%) will restrict intraday price movements significantly, while wider bands (20%) allow greater price discovery. This measure is part of BSE’s surveillance framework to manage volatility and protect investor interests in specific securities that may require enhanced monitoring or have specific risk characteristics.
Impact Justification
Routine price band revision affecting 20 securities, primarily impacting traders and market participants in these specific scrips with varying bands from 2% to 20%.